Clinical trial
A Prospective Multicenter Randomized Controlled Trial Comparing Fecal Microbiota Transplantation (FMT) to Placebo in the Treatment of Mild to Moderate Crohn's Disease
NCT03078803 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Randomized Controlled Trial Comparing Fecal Microbiota Transplantation (FMT) to Placebo in the Treatment of Mild to Moderate Crohn's Disease
- Lead sponsor
- University of Alberta
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 28, 2017
- Completion date
- August 29, 2022
- Enrollment
- 38 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.